Skip to content

Medical Grand Rounds: Outpatient COVID-19 Therapies in the Time of Omicron

In This Article

  • On January 6, 2022, the Department of Medicine at Massachusetts General Hospital co-hosted a virtual Harvard Medical Grand Rounds presentation related to SARS-CoV-2
  • Arthur Y. Kim, MD, COVID medical director of the Department of Medicine at Massachusetts General Hospital, Rajesh Gandhi, MD, director of HIV Clinical Services and Education, and experts from the local Boston community presented on outpatient COVID-19 therapies in the time of omicron

On January 6, 2022, the Department of Medicine at Massachusetts General Hospital held a virtual Harvard Medical Grand Rounds on COVID-19. Mass General's Arthur Y. Kim, MD, COVID medical director of the Department of Medicine, and Rajesh Gandhi, MD, director of HIV Clinical Services and Education, as well as experts from the local Boston community, presented on outpatient COVID-19 therapies in the time of omicron.

The session was moderated by Katrina Armstrong, MD, MS, physician-in-chief in the Department of Medicine at Mass General. Other speakers included Daniel Taupin, MD, medical director for COVID-19 Monoclonal Antibody Therapy at Beth Israel Deaconess Medical Center; Sigal Yawetz, MD, associate physician at Brigham and Women's Hospital; Daniel Kuritzkes, MD, chief of the Division of Infectious Diseases at Brigham and Women's Hospital; and Mary T. LaSalvia, MD, associate chief medical officer of Ambulatory at Beth Israel Deaconess Medical Center.

Watch the video »

View all COVID-19 updates

Learn about COVID-19 Grand Rounds at Mass General

Related topics

Related

On July 8, 2021, the inaugural Massachusetts Medical Grand Rounds was held on structural inequities during COVID-19The session was moderated by Katrina Armstong, MD, physician-in-chief in the Department of Medicine at Massachusetts General Hospital.

Related

Jacob Lemieux, MD, DPhil, of the Division of Infectious Diseases, Massachusetts General Hospital, and members of the Massachusetts Consortium on Pathogen Readiness (MassCPR) presented on the SARS-CoV-2 Variants of Concern